Read article—Karen Fortuna, assistant professor of community and family medicine, and Vedan Taplivana ’26, created an app for tracking Alzheimer’s progression. The app, called RealVision, tracks how users interact with their phones, noting such changes as disoriented eye movement, difficulty with typing, or needing more time to respond to prompts. “Some of these patterns are quite nuanced and may not be easily noticeable to the human eye in real time,” Fortuna said. “That’s where computational approaches can help by detecting patterns across many small signals over time.”

Red article—Features a clinical trial led by Shelby Sullivan, a professor of medicine, reporting that an outpatient procedure used to treat type 2 diabetes can help prevent people from regaining weight after discontinuing  GLP-1 drugs. “Finding a treatment that allows patients to stop these medications without weight regain or loss of metabolic benefit is a huge ​unmet need,” Sullivan said. (Similar coverage in New Hampshire Union Leader and HealthDay.)

Read article—Quotes Steven Woloshin, MED ’96, a professor of health policy and clinical practice and co-director of The Dartmouth Institute’s Center for Medicine and Media, who cautions patients to question telehealth providers. “It seems like you’re getting a bargain, but you’re taking your eye off the prize, which is: Do I have something that should be treated with a pill? Will this pill help me? Will the benefits outweigh the harms?” Woloshin said.

Read article—Comments by Paul Holtzheimer, a professor of psychiatry and surgery, underscore ongoing skepticism around psychedelic therapies amid growing advocacy and political momentum. “I don’t think we have the randomized control trial data yet on any of these agents to really say the data is there,” Holtzheimer said.

Read article—Shelby Sullivan, a professor of medicine, talks about the clinical trial she led showing that a minimally invasive procedure may help patients maintain weight loss after stopping GLP-1 drugs. The results will be presented May 4 at Digestive Disease Week 2026. “What’s particularly encouraging is that the benefit appears to increase over time rather than fade, and that it behaves like a drug in terms of dose response,” Sullivan said.

Read article—Researchers and professors from the Geisel School of Medicine propose a three-pillar framework to support the expansion of transcatheter aortic valve replacement to lower-risk, asymptomatic patient populations for aortic stenosis.

Listen to podcast—Charles Sentman, PHD, a professor of microbiology and immunology and Center for Synthetic Immunity director at Geisel is featured in a discussion on new strategies for overcoming the unique challenges of treating solid tumors.

Read article—Interview with Katie Lichter, an assistant professor of radiation oncology and health policy, and inaugural director of the new Division of Resilient and Sustainable Cancer Care in the Dartmouth Cancer Center. Lichter’s team is looking at how cancer treatment can impact the environment and how treatment can be impacted by climate change. “Do patients have a harder time recovering because their bodies are stressed by other factors? Whether that’s mental stress or actual stress from the poor air quality? We don’t know. But all things that we’re very interested in exploring further,” Lichter said.

Read article—In this article, VaccinesWork talks to Kendal Hoyt, assistant professor of medicine at Geisel, about how military research programs have played critical roles in the development of many new or improved vaccines, with a focus on the American military’s efforts during WW2.